Key result
Dinitrophenyl protection yields better synthetic foot-and-mouth disease virus peptides for monoclonal antibody testing.
Dinitrophenyl protection improves the synthesis of FMDV VP1 loop peptides, which can be used to study antigenic variability via monoclonal antibody reactivity.
Answers are grounded in this paper and cite their sources.
Dinitrophenyl protection may optimize FMDV peptide synthesis; leaves open translation to antigenic or vaccine applications.
Peptides representing the sequence of the immunodominant loop of foot-and-mouth disease virus strain C-S8 (YTASARGDLAHLTTTHARHLP, residues 136-156 of VP1) and of several variant viruses have been prepared by solid phase methods. In addition, five peptides with single-residue replacements at Leu147 (Ile, Nle, Val, Ala, Gly) have been synthesized. Tosyl and dinitrophenyl protections for histidine have been compared, the latter being found to give better synthetic products. The peptides have been tested in an immunodot assay against a panel of monoclonal antibodies directed towards the VP1 loop. Immunochemical results are discussed on the basis of the mobility of the region reproduced by the peptides and the nature of the side chain of residue 147.
No takes yet. Share an insight, caveat, or question.
Carreño et al. (1992) studied Foot-and-mouth disease virus. Synthetic peptides was evaluated on Immunochemical reactivity in an immunodot assay. Synthetic peptides representing the VP1 loop of foot-and-mouth disease virus were synthesized and tested against monoclonal antibodies, with dinitrophenyl protection yielding better synthetic products.
Synapse has enriched 10 related papers. Consider them for comparative context: